Retraction Note: Oligoprotective effect of metformin through the AMPK-dependent on restoration of mitochondrial hemostasis in the cuprizone-induced multiple sclerosis model
- PMID: 40632178
- DOI: 10.1007/s10735-025-10523-2
Retraction Note: Oligoprotective effect of metformin through the AMPK-dependent on restoration of mitochondrial hemostasis in the cuprizone-induced multiple sclerosis model
Retraction of
-
Oligoprotective effect of metformin through the AMPK-dependent on restoration of mitochondrial hemostasis in the cuprizone-induced multiple sclerosis model.J Mol Histol. 2019 Jun;50(3):263-271. doi: 10.1007/s10735-019-09824-0. Epub 2019 Apr 23. J Mol Histol. 2019. Retraction in: J Mol Histol. 2025 Jul 9;56(4):223. doi: 10.1007/s10735-025-10523-2. PMID: 31016544 Retracted.
Similar articles
-
Oligoprotective effect of metformin through the AMPK-dependent on restoration of mitochondrial hemostasis in the cuprizone-induced multiple sclerosis model.J Mol Histol. 2019 Jun;50(3):263-271. doi: 10.1007/s10735-019-09824-0. Epub 2019 Apr 23. J Mol Histol. 2019. Retraction in: J Mol Histol. 2025 Jul 9;56(4):223. doi: 10.1007/s10735-025-10523-2. PMID: 31016544 Retracted.
-
SAMe and DADS attenuated cuprizone-induced demyelination via modulating H2S/AMPK/SIRT1/ULK1/beclin1 signaling.Chem Biol Interact. 2025 Sep 5;418:111617. doi: 10.1016/j.cbi.2025.111617. Epub 2025 Jun 24. Chem Biol Interact. 2025. PMID: 40571174
-
Metformin protects the heart against chronic intermittent hypoxia through AMPK-dependent phosphorylation of HIF-1α.FEBS J. 2025 Aug;292(15):3942-3959. doi: 10.1111/febs.70110. Epub 2025 May 13. FEBS J. 2025. PMID: 40364612
-
Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification.J Cancer Res Clin Oncol. 2016 Oct;142(10):2159-71. doi: 10.1007/s00432-016-2178-4. Epub 2016 May 9. J Cancer Res Clin Oncol. 2016. PMID: 27160287 Free PMC article. Review.
-
The effects of melatonin supplementation on neurobehavioral outcomes and clinical severity in rodent models of multiple sclerosis; a systematic review and meta-analysis.Inflammopharmacology. 2024 Apr;32(2):927-944. doi: 10.1007/s10787-023-01414-7. Epub 2024 Jan 22. Inflammopharmacology. 2024. PMID: 38252220
Publication types
LinkOut - more resources
Full Text Sources